Document Type : Original Article
Authors
- Mahdieh Jamshidi 1, 2
- Zahra Kamiab 3
- Maryam Karimifard 1, 2
- Mohammadreza Shafiepour 1, 2
- Gholamreza Bazmandegan 4, 5
1 Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
2 Clinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
3 Department of Community Medicine, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
4 Physiology-Pharmacology Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
5 Department of Physiology and Pharmacology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Abstract
Introduction: This study investigated hemoglobin concentration in chronic renal failure (CRF) patients with and without diabetes referred to the Rafsanjan Diabetes Clinic from 2021 to 2022.
Methods: In this descriptive study, 112 patients with chronic renal failure from the diabetes clinic at Ali-ibn Abi-Talib Hospital were selected using a convenience sampling method and examined. Chronic kidney disease patients not undergoing hemodialysis were included, and patients with specific blood conditions, a history of blood transfusions, or incomplete records were excluded. Demographic and clinical parameters were collected using a researcher-made checklist. SPSS 24 software was used for data analysis.
Results: In this study, 120 CRF patients, averaging 63.90 years old, were evaluated, divided into two groups: those with (n = 64) and those without (n = 56) diabetes. Results indicated that diabetic patients had significantly higher body mass index and a higher mean age compared to non-diabetic patients (p < 0.001). Laboratory analyses revealed that the diabetic group showed elevated levels of urea, HbA1c, and fasting blood sugar, higher rates of anemia, and reduced levels of hemoglobin (all p < 0.001). A logistic regression analysis revealed that diabetes significantly increases the risk of developing anemia among CRF patients, nearly tripling the likelihood (OR = 3.110, p = 0.494).
Conclusion: The results showed that CRF in patients with diabetes was associated with disorders such as lower hemoglobin levels, anemia, and higher HbA1c. Even though this disorder itself can cause adverse effects in diabetic patients, it is necessary to continuously evaluate the mentioned indicators in these patients, since in the long term, they will aggravate the symptoms and severity of the disease.
Keywords
Main Subjects
- Loscalzo J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL. Harrison’s Principles of Internal Medicine. McGraw Hill; 2022.
- Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon) 2014;42(12):698-702. doi:10.1016/j. mpmed.2014.09.007
- American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2016;39(Suppl 1): S13-22.
- Guo W, Zhou Q, Jia Y, Xu J. Increased levels of glycated hemoglobin A1c and iron deficiency anemia: a review. Med Sci Monit 2019;25:8371-8. doi:10.12659/msm.916719
- Khusun H, Yip R, Schultink W, Dillon DH. World Health Organization hemoglobin cut-off points for the detection of anemia are valid for an Indonesian population. J Nutr 1999;129(9):1669-74. doi:10.1093/jn/129.9.1669
- Vanholder R, Fouque D, Glorieux G, Heine GH, Kanbay M, Mallamaci F, et al. Clinical management of the uraemic syndrome in chronic kidney disease. Lancet Diabetes Endocrinol 2016;4(4):360-73. doi:10.1016/s2213-8587(16)00033-4
- Thomas MC, Tsalamandris C, Macisaac R, Jerums G. Functional erythropoietin deficiency in patients with type 2 diabetes and anaemia. Diabet Med 2006;23(5):502-9. doi:10.1111/j.1464- 5491.2006.01829.x
- Craig KJ, Williams JD, Riley SG, Smith H, Owens DR, Worthing D, et al. Anemia and diabetes in the absence of nephropathy. Diabetes Care 2005;28(5):1118-23. doi:10.2337/ diacare.28.5.1118
- Grossman C, Dovrish Z, Koren-Morag N, Bornstein G, Leibowitz A. Diabetes mellitus with normal renal function is associated with anaemia. Diabetes Metab Res Rev 2014;30(4):291-6. doi:10.1002/dmrr.2491
- Al-Khoury S, Afzali B, Shah N, Covic A, Thomas S, Goldsmith DJ. Anaemia in diabetic patients with chronic kidney disease- -prevalence and predictors. Diabetologia 2006;49(6):1183-9. doi:10.1007/s00125-006-0254-z
- Bonakdaran S, Gharebaghi M, Vahedian M. Prevalence of anemia in type 2 diabetes and role of renal involvement. Saudi J Kidney Dis Transpl 2011;22(2):286-90.
- Thomas MC, Tsalamandris C, MacIsaac RJ, Jerums G. The epidemiology of hemoglobin levels in patients with type 2 diabetes. Am J Kidney Dis 2006;48(4):537-45. doi:10.1053/j. ajkd.2006.06.011
- Lo C, Lui M, Ranasinha S, Teede HJ, Kerr PG, Polkinghorne KR, et al. Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease. Diabetes Res Clin Pract 2014;104(1):84-91. doi:10.1016/j.diabres.2014.01.020
- El-Achkar TM, Ohmit SE, McCullough PA, Crook ED, Brown WW, Grimm R, et al. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. Kidney Int 2005;67(4):1483-8. doi:10.1111/j.1523-1755.2005.00226.x
- Heidari B, Heidari P, Hajian-Tilaki K. Association between serum vitamin D deficiency and knee osteoarthritis. Int Orthop 2011;35(11):1627-31. doi:10.1007/s00264-010-1186-2
- Portolés J, Martín L, Broseta JJ, Cases A. Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents. Front Med (Lausanne) 2021;8:642296. doi:10.3389/fmed.2021.642296
- Atkinson MA, Warady BA. Anemia in chronic kidney disease. Pediatr Nephrol 2018;33(2):227-38. doi:10.1007/s00467-017- 3663-y
- Atkinson MA, Martz K, Warady BA, Neu AM. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr Nephrol 2010;25(9):1699-706. doi:10.1007/s00467- 010-1538-6
- Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, et al. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2009;4(1):48- 56. doi:10.2215/cjn.05301107
- Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One 2014;9(1): e84943. doi:10.1371/journal.pone.0084943
- Smith RE Jr. The clinical and economic burden of anemia. Am J Manag Care 2010;16 Suppl Issues: S59-66.
- Nelson RG, Tuttle KR. The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD. Blood Purif 2007;25(1):112-4. doi:10.1159/000096407
- Cawood TJ, Buckley U, Murray A, Corbett M, Dillon D, Goodwin B, et al. Prevalence of anaemia in patients with diabetes mellitus. Ir J Med Sci 2006;175(2):25-7. doi:10.1007/ bf03167944
- Ezenwaka CE, Jones-Lecointe A, Nwagbara E, Seales D, Okali F. Anaemia and kidney dysfunction in Caribbean type 2 diabetic patients. Cardiovasc Diabetol 2008;7:25. doi:10.1186/1475- 2840-7-25
- Angelousi A, Larger E. Anaemia, a common but often unrecognized risk in diabetic patients: a review. Diabetes Metab 2015;41(1):18-27. doi:10.1016/j.diabet.2014.06.001
- Kene K, Wondimnew T, Welde M, Mateos T, Adugna T, Gerema U, et al. Prevalence and determinants of Impaired Serum Creatinine and Urea among type 2 diabetic patients of Jimma Medical Center, Jimma, Southwestern Ethiopia, 2019. Endocr Metab Sci 2021;3:100096. doi:10.1016/j.endmts.2021.100096
- Koppe L, Nyam E, Vivot K, Manning Fox JE, Dai XQ, Nguyen BN, et al. Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease. J Clin Invest 2016;126(9):3598-612. doi:10.1172/jci86181
- Kamal A. Impact of diabetes on renal function parameters. Ind J Fund Appl Life Sci 2014;4(3):411-6.
- Salazar JH. Overview of urea and creatinine. Lab Med 2014;45(1): e19-20. doi:10.1309/LM920SBNZPJRJGUT
- D’Apolito M, Du X, Zong H, Catucci A, Maiuri L, Trivisano T, et al. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 2010;120(1):203- 13. doi:10.1172/jci37672
- Luk AO, Ma RC, Lau ES, Yang X, Lau WW, Yu LW, et al. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Diabetes Metab Res Rev 2013;29(5):384-90. doi:10.1002/dmrr.2404
- Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes 2009;58(11):2649-55. doi:10.2337/db09-0693
- Kang SH, Jung DJ, Choi EW, Cho KH, Park JW, Do JY. HbA1c levels are associated with chronic kidney disease in a non-diabetic adult population: a nationwide survey (KNHANES 2011-2013). PLoS One 2015;10(12): e0145827. doi:10.1371/ journal.pone.0145827
- Bomholt T, Adrian T, Nørgaard K, Ranjan AG, Almdal T, Larsson A, et al. The use of HbA1c, glycated albumin and continuous glucose monitoring to assess glucose control in the chronic kidney disease population including dialysis. Nephron 2021;145(1):14-9. doi:10.1159/000511614
- American Diabetes Association. Standards of medical care in diabetes-2017. Diabetes Care 2017;40(Suppl 1): S1-135.
- Copur S, Onal EM, Afsar B, Ortiz A, van Raalte DH, Cherney DZ, et al. Diabetes mellitus in chronic kidney disease: biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality. J Diabetes Complications 2020;34(11):107707. doi:10.1016/j.jdiacomp.2020.107707
)